Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Psoriasin (S100A7) increa… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Psoriasin (S100A7) increases the expression of ROS and VEGF and acts through RAGE to promote endothelial cell proliferation.

Artikel i vetenskaplig tidskrift
Författare Emman Shubbar
Jenny Vegfors
Maria Carlström
Stina Petersson
Charlotta Enerbäck
Publicerad i Breast cancer research and treatment
Volym 134
Nummer/häfte 1
Sidor 71-80
ISSN 1573-7217
Publiceringsår 2012
Publicerad vid
Sidor 71-80
Språk en
Ämnesord Antigens, Neoplasm, genetics, metabolism, Breast Neoplasms, Cell Line, Tumor, Cell Proliferation, drug effects, Female, Gene Expression, drug effects, Gene Knockdown Techniques, Human Umbilical Vein Endothelial Cells, drug effects, metabolism, physiology, Humans, Mitogen-Activated Protein Kinases, genetics, metabolism, Neovascularization, Pathologic, metabolism, RNA Interference, Reactive Oxygen Species, metabolism, Recombinant Proteins, genetics, metabolism, S100 Proteins, genetics, metabolism, physiology, Up-Regulation, Vascular Endothelial Growth Factor A, genetics, metabolism
Ämneskategorier Klinisk medicin

Sammanfattning

Psoriasin (S100A7), originally identified in psoriasis, is a calcium-binding protein belonging to the multigenic S100 family. In high-grade ductal carcinoma in situ, psoriasin was identified as one of the most abundant transcripts. We have previously shown that psoriasin was induced by reactive oxygen species (ROS). Moreover, the downregulation of psoriasin by short hairpin RNA (shRNA) led to the reduced expression of vascular endothelial growth factor (VEGF) and inhibited tumor growth in vivo. The aim of the present study was to investigate whether psoriasin could have direct effects on endothelial cells. In this study we demonstrated that psoriasin increased VEGF expression in mammary epithelial cells. The treatment of endothelial cells with recombinant psoriasin increased proliferation comparable to that of recombinant VEGF protein. No change in proliferation was seen when endothelial cells were infected with psoriasin-expressing adenoviruses, suggesting that the proliferative effect of psoriasin was mediated by a specific receptor. Treatment with sRAGE, targeting the receptor for advanced glycation end products (RAGE), thus inhibited endothelial cell proliferation and tube formation enhanced by recombinant psoriasin. We showed that VEGF expression was not induced by hydrogen peroxide, when psoriasin was silenced by shRNA, which led to the hypothesis that psoriasin induces ROS. Indeed, psoriasin was shown to induce ROS in both endothelial and epithelial cells. Moreover, sRAGE inhibited the psoriasin-dependent generation of ROS in endothelial cells. Finally, treatment with antioxidant Bcl-2 protein abolished the effect of psoriasin on endothelial cell proliferation. Our data suggest that psoriasin expression in mammary epithelial cells leads to increased endothelial cell proliferation in a paracrine manner through RAGE. Psoriasin may therefore play a role in breast cancer progression by promoting oxidative stress response and angiogenesis.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?